Icon PLC | Income Statement

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,336
1,503
1,575
1,666
1,758
2,596
Cost of Goods Sold (COGS) incl. D&A
892
956
967
1,021
1,089
1,884
Gross Income
444
548
608
646
670
712
SG&A Expense
315
342
330
324
322
330
EBIT
129
205
-
322
348
382
Unusual Expense
9
9
-
8
2
12
Non Operating Income/Expense
1
6
4
2
8
4
Interest Expense
1
1
4
13
13
14
Pretax Income
121
203
279
300
328
365
Income Tax
18
30
39
38
47
42
Consolidated Net Income
103
172
240
262
281
323
Net Income
103
172
240
262
281
323
Net Income After Extraordinaries
103
172
240
262
281
323
Net Income Available to Common
103
172
240
262
281
323
EPS (Basic)
1.69
2.80
4.08
4.75
5.20
5.96
Basic Shares Outstanding
61
61
59
55
54
54
EPS (Diluted)
1.65
2.73
3.97
4.65
5.13
5.89
Diluted Shares Outstanding
62
63
60
56
55
55
EBITDA
175
258
336
382
409
448
Non-Operating Interest Income
1
1
1
1
2
5

About Icon

View Profile
Address
South County Business Park
Dublin Dublin 18
Ireland
Employees -
Website http://www.iconplc.com
Updated 07/08/2019
ICON plc is a contract research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It operates through the following geographical segments: Ireland, Rest of Europe, United States, and Other. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.